Esperion Therapeutics, Inc. short interest in 2020
In 2020, Esperion Therapeutics, Inc.'s disclosed short interest ran from 17.67% of shares outstanding on 15 Jan 2020 to 38.68% on 31 Dec 2020, a change of +21.01 percentage points. The year's high was 41.56% on 31 Aug 2020 and its low 17.67% on 15 Jan 2020, averaging 32.07% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.77 days on 30 Sep 2020. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 17.67% (15 Jan 2020)
- End of year
- 38.68% (31 Dec 2020)
- Change
- +21.01 pp
- High
- 41.56% (31 Aug 2020)
- Low
- 17.67% (15 Jan 2020)
- Average
- 32.07%
- Highest days to cover
- 26.77 (30 Sep 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 17.67% | 13.04 | |
| 31 Jan 2020 | 17.89% | 9.56 | |
| 14 Feb 2020 | 19.10% | 7.04 | |
| 28 Feb 2020 | 24.91% | 4.65 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 22.57% | 7.20 | |
| 31 Mar 2020 | 25.46% | 7.81 | |
| 15 Apr 2020 | 27.65% | 11.20 | |
| 30 Apr 2020 | 28.20% | 14.35 | |
| 15 May 2020 | 30.22% | 12.21 | 10-Q filed, results (8-K) |
| 29 May 2020 | 29.42% | 12.37 | |
| 15 Jun 2020 | 33.92% | 16.34 | |
| 30 Jun 2020 | 36.67% | 14.86 | |
| 15 Jul 2020 | 37.96% | 24.85 | |
| 31 Jul 2020 | 39.40% | 19.23 | |
| 14 Aug 2020 | 39.55% | 13.35 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 41.56% | 20.90 | |
| 15 Sep 2020 | 40.15% | 25.58 | |
| 30 Sep 2020 | 40.03% | 26.77 | |
| 15 Oct 2020 | 36.40% | 22.48 | |
| 30 Oct 2020 | 36.16% | 23.45 | |
| 13 Nov 2020 | 34.75% | 7.85 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 35.09% | 17.61 | |
| 15 Dec 2020 | 36.29% | 25.91 | |
| 31 Dec 2020 | 38.68% | 17.36 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.